Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/14 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 96
- 較 2024 年第 2 季 +11
- 總值
- $3.22 億
- 較 2024 年第 2 季 +$154.2 萬 (+0.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,030,277 | $3,389 萬 | 10.5% | +230,000+28.7% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 426,913 | $2,182 萬 | 6.8% | −161,905−27.5% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 499,566 | $1,276 萬 | 4.0% | −86,986−14.8% | 減碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 744,000 | $1,138 萬 | 3.5% | +599,000+413.1% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 499,977 | $1,137 萬 | 3.5% | +499,977 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 154,835 | $1,130 萬 | 3.5% | +107,000+223.7% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 221,437 | $1,118 萬 | 3.5% | −224,014−50.3% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 179,000 | $994.3 萬 | 3.1% | +179,000 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 970,359 | $921.8 萬 | 2.9% | +915,629+1,673.0% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 170,147 | $898.4 萬 | 2.8% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 302,247 | $888.9 萬 | 2.8% | +302,247 | 新進 | 歷史 |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 417,850 | $830.7 萬 | 2.6% | −100,536−19.4% | 減碼 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 267,145 | $809.4 萬 | 2.5% | +204,309+325.1% | 加碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 85,000 | $786.3 萬 | 2.4% | +85,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 285,613 | $727.2 萬 | 2.3% | −46,400−14.0% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 54,176 | $676.6 萬 | 2.1% | −149,436−73.4% | 減碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 284,715 | $587.4 萬 | 1.8% | −24,825−8.0% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 260,000 | $584.2 萬 | 1.8% | −180,500−41.0% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 52,238 | $534.4 萬 | 1.7% | −99,363−65.5% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 115,200 | $505.6 萬 | 1.6% | +115,200 | 新進 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 693,350 | $490.9 萬 | 1.5% | +693,350 | 新進 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 204,513 | $485.5 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 300,000 | $456.3 萬 | 1.4% | +300,000 | 新進 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 544,265 | $446.3 萬 | 1.4% | −30,823−5.4% | 減碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 887,230 | $430.3 萬 | 1.3% | −16,514−1.8% | 減碼 | 歷史 |
| AMGNAmgen Inc | Stock | 13,300 | $428.5 萬 | 1.3% | −25,000−65.3% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 107,187 | $422.0 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| EOLSEvolus, Inc. | COM | 258,279 | $418.4 萬 | 1.3% | +258,279 | 新進 | 歷史 |
| ABEOAbeona Therapeutics Inc. | COM NEW | 583,593 | $368.8 萬 | 1.1% | −185,000−24.1% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 197,096 | $364.0 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 957,408 | $351.4 萬 | 1.1% | −705,000−42.4% | 減碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 587,343 | $337.4 萬 | 1.0% | +80,678+15.9% | 加碼 | 歷史 |
| SLRNACELYRIN, Inc. | COM | 677,074 | $333.8 萬 | 1.0% | −798,000−54.1% | 減碼 | 歷史 |
| HELPHelus Pharma Inc. | COM NEW | 367,195 | $326.4 萬 | 1.0% | +367,195 | 新進 | 歷史 |
| CRVOCervoMed Inc. | COM | 202,345 | $295.4 萬 | 0.9% | −35,000−14.7% | 減碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 108,483 | $278.9 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 308,497 | $257.3 萬 | 0.8% | −150,000−32.7% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 8,741 | $240.4 萬 | 0.7% | +8,741 | 新進 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 257,216 | $232.5 萬 | 0.7% | +257,216 | 新進 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 180,000 | $218.0 萬 | 0.7% | +180,000 | 新進 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM | 1,025,668 | $174.4 萬 | 0.5% | +1,025,668 | 新進 | 歷史 |
| NKTRNektar Therapeutics | COM | 1,312,405 | $170.6 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 311,593 | $165.1 萬 | 0.5% | +311,593 | 新進 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 88,167 | $164.1 萬 | 0.5% | +88,167 | 新進 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,443,181 | $147.2 萬 | 0.5% | 00.0% | 不變 | – |
| IBIOiBio, Inc. | COM NEW | 600,000 | $133.2 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 202,908 | $127.8 萬 | 0.4% | −100,000−33.0% | 減碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 476,586 | $124.4 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 706,154 | $124.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 100,609 | $116.1 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 92,000 | $109.8 萬 | 0.3% | +92,000 | 新進 | 歷史 |
| IFRXInflaRx N.V. | COM | 704,987 | $107.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 387,565 | $107.4 萬 | 0.3% | −25,000−6.1% | 減碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 55,175 | $103.8 萬 | 0.3% | −50,000−47.5% | 減碼 | 歷史 |
| HLSQTessera Defense & Homeland Security Inc. | COM NEW | 893,000 | $91.1 萬 | 0.3% | +893,000 | 新進 | 歷史 |
| DCTHDelcath Systems, Inc. | COM NEW | 100,370 | $90.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 175,100 | $89.1 萬 | 0.3% | +75,100+75.1% | 加碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 274,551 | $89.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 483,583 | $88.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM NEW | 52,193 | $84.1 萬 | 0.3% | −190,177−78.5% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 1,068,992 | $82.7 萬 | 0.3% | +200,000+23.0% | 加碼 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 170,000 | $82.3 萬 | 0.3% | +170,000 | 新進 | 歷史 |
| IMUXImmunic, Inc. | COM | 493,496 | $81.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 78,574 | $80.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 367,965 | $76.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VERUVeru Inc. | COM | 946,382 | $72.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 526,066 | $72.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 466,019 | $70.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 266,435 | $66.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 42,123 | $66.0 萬 | 0.2% | −187,877−81.7% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 972,675 | $63.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMTXImmatics N.V. | SHS | 49,415 | $56.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NYXHNyxoah SA | COMMONSTOCK | 50,699 | $48.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 192,647 | $42.0 萬 | 0.1% | −250,000−56.5% | 減碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 690,089 | $41.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FTHFaeth Therapeutics, Inc. | COM | 650,000 | $38.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 58,528 | $38.3 萬 | 0.1% | −265,000−81.9% | 減碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 62,481 | $35.6 萬 | 0.1% | −100,000−61.5% | 減碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 409,355 | $34.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 213,392 | $33.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 55,857 | $32.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 154,625 | $31.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 157,862 | $30.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 155,712 | $28.5 萬 | 0.1% | −25,000−13.8% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 1,056,829 | $27.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| AEONAEON Biopharma, Inc. | CL A | 257,977 | $27.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 75,000 | $26.8 萬 | 0.1% | +75,000 | 新進 | 歷史 |
| MGNXMacrogenics Inc | COM | 80,079 | $26.3 萬 | 0.1% | −120,000−60.0% | 減碼 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 53,076 | $22.8 萬 | 0.1% | +53,076 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 83,282 | $19.1 萬 | 0.1% | −275,000−76.8% | 減碼 | 歷史 |
| TPSTTempest Therapeutics, Inc. | COM | 105,600 | $14.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 40,369 | $13.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 6,816 | $8.38 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SYBXSynlogic, Inc. | COM NEW | 20,448 | $3.05 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 8,924 | $1.05 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 39 | $421 | <0.1% | +39 | 新進 | 歷史 |
選擇權（35 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | Stock | $4,651 萬 | $4,651 萬 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $4,940 萬 | – |
| AMGNAmgen Inc | Stock | – | $4,704 萬 |
| ANABAnaptysbio, Inc | COM | $1,354 萬 | $1,173 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $1,038 萬 | $1,038 萬 |
| JANXJanux Therapeutics, Inc. | COM | $1,659 萬 | – |
| BHVNBiohaven Ltd. | COM | $1,627 萬 | – |
| IMVTImmunovant, Inc. | COM | – | $1,426 萬 |
| NMRANeumora Therapeutics, Inc. | COM | $528.4 萬 | $528.4 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | $576.8 萬 | $432.6 萬 |
| ANROAlto Neuroscience, Inc. | COM SHS | $514.8 萬 | $493.1 萬 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $456.3 萬 | $456.3 萬 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | $413.3 萬 | $304.5 萬 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | $480.9 萬 | $222.4 萬 |
| ONCBeOne Medicines Ltd. | ADR | – | $669.0 萬 |
| AKROAkero Therapeutics, Inc. | COM | $570.6 萬 | – |
| SLNOSoleno Therapeutics Inc | COM | – | $555.4 萬 |
| SANASana Biotechnology, Inc. | COM | $270.4 萬 | $270.4 萬 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | $498.7 萬 | – |
| DYNDyne Therapeutics, Inc. | COM | $477.7 萬 | – |
| VRDNViridian Therapeutics, Inc. | COM | – | $455.0 萬 |
| SRRKScholar Rock Holding Corp | COM | $161.9 萬 | $161.9 萬 |
| CYTKCytokinetics Inc | COM NEW | – | $276.1 萬 |
| GALTGalectin Therapeutics Inc | COM NEW | $137.5 萬 | $137.5 萬 |
| SLDBSolid Biosciences Inc. | COM NEW | – | $209.1 萬 |
| RCUSArcus Biosciences, Inc. | COM | – | $173.8 萬 |
| FULCFulcrum Therapeutics, Inc. | COM | $8.14 萬 | $150.9 萬 |
| SWTXSpringWorks Therapeutics, Inc. | COM | – | $140.3 萬 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | – | $131.6 萬 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | – | $115.3 萬 |
| CATXPerspective Therapeutics, Inc. | COM NEW | $102.9 萬 | – |
| BMEABiomea Fusion, Inc. | COM | $53.5 萬 | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | – | $48.3 萬 |
| PRTAProthena Corp Public Ltd Co | SHS | $19.7 萬 | $19.7 萬 |
| APGEApogee Therapeutics, Inc. | COM | – | $29.4 萬 |
2024 年第 2 季之後清倉（10 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| VKTXViking Therapeutics, Inc. | COM | 138,262 | $732.9 萬 | 2.3% | 歷史 |
| IMVTImmunovant, Inc. | COM | 276,925 | $731.1 萬 | 2.3% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 40,000 | $550.7 萬 | 1.7% | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 489,642 | $455.4 萬 | 1.4% | 歷史 |
| Cybin Ord23256X100 | COM | 13,953,488 | $378.1 萬 | 1.2% | – |
| VRNAVerona Pharma plc | SPONSORED ADS | 201,116 | $290.8 萬 | 0.9% | 歷史 |
| QTTBQ32 Bio Inc. | COM | 109,094 | $195.8 萬 | 0.6% | 歷史 |
| ANNXAnnexon, Inc. | COM | 380,000 | $186.2 萬 | 0.6% | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 183,701 | $153.0 萬 | 0.5% | 歷史 |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 90,242 | $3.05 萬 | <0.1% | 歷史 |